跳至主要内容
临床试验/NCT03936244
NCT03936244已完成不适用

Randomized Controlled Trial Comparing Bipolar Plasmakinetic Transurethral Resection of the Prostate With Monopolar Transurethral Resection of the Prostate in the Treatment of Lower Urinary Tract Symptoms Due to Benign Prostatic Hyperplasia

Hospital Universitario de Fuenlabrada2 个研究点 分布在 1 个国家目标入组 100 人开始时间: 2014年12月5日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
100
试验地点
2
主要终点
Postvoid Residual Urine (PVRU) Volume

研究概览

简要总结

Randomized controlled trial with one-year follow-up comparing intra, peri and postoperative outcomes for plasmakinetic transurethral resection of prostate (PK-TURP) and monopolar transurethral resection of prostate (M-TURP) in the treatment of LUTS due to BPH in a tertiary-care public institution

详细描述

The study is a randomized controlled trial with one-year follow-up comparing intra, peri and postoperative outcomes (efficacy, complications and sequelae) for plasmakinetic transurethral resection of prostate (PK-TURP) and monopolar transurethral resection of prostate (M-TURP) in the treatment of LUTS due to BPH in a tertiary-care public institution (Madrid, Spain)

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Single (Participant)

入排标准

性别
Male
接受健康志愿者

入选标准

  • Sign the informed consent voluntarily and will be willing to follow-up
  • Prostate volume <80 g
  • Meet any conditions (1) Diagnose of LUTS due to refractory to drugs BPH. (2) presenting complications derived from BPH (bladder calculi, recurrent haematuria, recurrent urinary tract infections, acute urinary retention)
  • The use of antiplatelet agents or anticoagulant drugs is allowed.

排除标准

  • Previous history of pelvic surgery
  • Previous history of pelvic radiotherapy
  • Previous history of neurogenic bladder dysfunction
  • Documented or suspected prostate carcinoma
  • Patients with severe cardiopulmonary disease or severe mental disorders
  • Poor compliance, and can not be followed up.

结局指标

主要结局

Postvoid Residual Urine (PVRU) Volume

时间窗: 12 months

Postvoid residual urine volume (mL) was measured by abdominal ultrasound after urination at 1, 3, 6, and 12 months after surgery.

International Prostate Symptom Score (IPSS)

时间窗: 12 months

International Prostate Symptom Score (with 7 questions) at 1, 3, 6, and 12 months after surgery. Results: the sum of the 7 items will range between 0 to 35 points Interpretation: allows categorizing the lower urinary tract symptoms (LUTS) in 3 categories * Mild LUTS: 0-7 points * Moderate LUTS: 8-19 points * Severe LUTS: 20-35 points

Maximum Urinary Flow Rate (Qmax

时间窗: 12 months

Maximum urinary flow rate (mL/s) at 1, 3, 6, and 12 months after surgery.

次要结局

  • Number of Participants Reporting Sexual Activity in the Last Month(12 months)
  • Operative Time(Up to 24 hours)
  • Hospital Stay(1 month)
  • Change in Plasmatic Sodium in 24 Hours Post-operation(24 hours after surgery)
  • Catheter Duration(1 month)
  • Quality of Life (QoL): Bother Score Item of the IPSS Questionnaire(12 months)
  • International Index of Erectile Function (IIEF-5)(12 months)
  • Prostate Volume (PV)(12 months)
  • Irrigation Volume(Up to 24 hours)
  • Change in Haemoglobin in 24 Hours Post-operation(24 hours after surgery)
  • Transfusion Rate(1 month)
  • Resected Tissue Weigh(Up to 24 hours)
  • Speed Resection(Up to 24 hours)
  • Sequelae Rate: Retrograde Ejaculation(12 months)
  • Resected Tissue Percentage(Up to 24 hours)
  • Late Reoperation Rate(12 months)
  • Early Reoperation Rate(1 month)
  • Post-TURP Syndrome Rate(Up to 24 hours)
  • Bleeding Complications Rate(1 month)
  • Urinary Tract Infections Rate(12 months)
  • Stenotic Complications Rate: Meatal Stenosis(12 months)
  • Stenotic Complications Rate: Urethral Stricture(12 months)
  • Urge Urinary Incontinence With Need for Drug Use (UUIND) Rate(12 months)
  • Urge Urinary Incontinence Without Need for Drug Use (UUIWND) Rate(12 months)
  • Sequelae Rate: Dysuria(12 months)
  • Stenotic Complications Rate: Bladder Neck Contracture(12 months)
  • Stress Urinary Incontinence Rate(12 months)
  • Clavien Dindo System(12 months)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Carolina Alonso

Attending physician

Hospital Universitario de Fuenlabrada

研究点 (2)

Loading locations...

相似试验